Skip to main content

Bank of New York Mellon Corp

Bank

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1390777 NEW YORK, NY

Position in AVBP

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,740,584
+$269,591 QoQ
Shares Held
75,448
+3.2% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. AVBP ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVBP

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,740,584 75,448
2025-12-31 $1,470,993 73,111
2025-09-30 $1,167,570 63,283
2025-06-30 $1,279,597 58,778
2025-03-31 $1,261,479 68,225
2024-12-31 $1,811,599 68,003
2024-09-30 $1,605,543 68,321
2024-06-30 $553,660 29,847
2024-03-31 $405,546 22,707